Want to join the conversation?
CitiGroup analyst Jonathan Raviv questions $SAIC whether it is fair to see $240MM of free cash flow for FY17, excluding the extra pay period giving about $216MM free cash flow this year. CFO John Hartley says that's the fair estimate. As $SAIC grow, the $240MM of FCF will grow as well, provided it does not look at high working capital business.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.